These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12438686)

  • 1. A genomic-scale view of the cAMP response element-enhancer decoy: a tumor target-based genetic tool.
    Cho YS; Kim MK; Cheadle C; Neary C; Park YG; Becker KG; Cho-Chung YS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15626-31. PubMed ID: 12438686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRE-enhancer DNA decoy: a tumor target-based genetic tool.
    Cho-Chung YS
    Ann N Y Acad Sci; 2003 Dec; 1002():124-33. PubMed ID: 14751830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth.
    Park YG; Nesterova M; Agrawal S; Cho-Chung YS
    J Biol Chem; 1999 Jan; 274(3):1573-80. PubMed ID: 9880535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRE-decoy oligonucleotide-inhibition of gene expression and tumor growth.
    Cho-Chung YS; Park YG; Nesterova M; Lee YN; Cho YS
    Mol Cell Biochem; 2000 Sep; 212(1-2):29-34. PubMed ID: 11108133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct involvement of cAMP-response element-dependent transcriptions in functional and morphological maturation during retinoid-mediated human myeloid differentiation.
    Saeki K; Saeki K; Yuo A
    J Leukoc Biol; 2003 May; 73(5):673-81. PubMed ID: 12714583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: protein kinase A downregulation and cytoplasmic export of CRE-binding proteins.
    Alper O; Bergmann-Leitner ES; Abrams S; Cho-Chung YS
    Mol Cell Biochem; 2001 Feb; 218(1-2):55-63. PubMed ID: 11330838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy.
    Cho-Chung YS; Nesterova M; Becker KG; Srivastava R; Park YG; Lee YN; Cho YS; Kim MK; Neary C; Cheadle C
    Ann N Y Acad Sci; 2002 Jun; 968():22-36. PubMed ID: 12119265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotides as transcription factor decoys.
    Cho-Chung YS; Park YG; Lee YN
    Curr Opin Mol Ther; 1999 Jun; 1(3):386-92. PubMed ID: 11713803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.
    Lee YN; Park YG; Choi YH; Cho YS; Cho-Chung YS
    Biochemistry; 2000 Apr; 39(16):4863-8. PubMed ID: 10769144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense DNAs as multisite genomic modulators identified by DNA microarray.
    Cho YS; Kim MK; Cheadle C; Neary C; Becker KG; Cho-Chung YS
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9819-23. PubMed ID: 11481453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2.
    Feuerstein N; Huang D; Hinrichs SH; Orten DJ; Aiyar N; Prystowsky MB
    J Immunol; 1995 Jan; 154(1):68-79. PubMed ID: 7995960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of gene therapy with a cyclic adenosine monophosphate response element decoy oligodeoxynucleotide to prevent vascular intimal hyperplasia.
    Uchida D; Saito Y; Kikuchi S; Yoshida Y; Hirata S; Sasajima T; Azuma N
    J Vasc Surg; 2020 Jan; 71(1):229-241. PubMed ID: 31204215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of the protein CRE-BP1: heterogeneity of the protein that binds to the cAMP-responsive element.
    Ishii S; Maekawa T; Sudo T; Sakurai A; Yasuda I; Kishimoto A
    Adv Second Messenger Phosphoprotein Res; 1990; 24():335-9. PubMed ID: 2169813
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
    Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
    Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for the involvement of at least two distinct transcription factors, one of which is liver-enriched, for the activation of the phosphoenolpyruvate carboxykinase gene promoter by cAMP.
    Roesler WJ; McFie PJ; Puttick DM
    J Biol Chem; 1993 Feb; 268(5):3791-6. PubMed ID: 8381439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells.
    Taki K; Kogai T; Kanamoto Y; Hershman JM; Brent GA
    Mol Endocrinol; 2002 Oct; 16(10):2266-82. PubMed ID: 12351692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R.
    Groussin L; Massias JF; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2000 Jan; 85(1):345-54. PubMed ID: 10634409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.